Calreticulin is best known as a multifunctional endoplasmic reticulum resident, calcium binding protein with chaperone function. However, calreticulin has been reported on the surface of some cells where it can participate in a variety cell functions. We have shown that calreticulin is present on the surface of circulating PMN and since calreticulin lacks a transmembrane domain, it must bind to an adaptor protein, that is resident in the PMN plasma membrane. Preliminary data indicate that the adaptor for calreticulin on PMN is resident in lipid rafts and GPI-anchored. Reciprocal immunoprecipitation-and immunoblotting with anti-calreticulin and anti-CD59 identify CD59 as the adaptor protein on PMN. Calreticulin is known to have immune functions and this proposal will focus on how PMN utilize surface calreticulin. PMN have a critical role in innate immunity as the primary phagocyte. We hypothesize that PMN use surface calreticulin to both prime the adaptive immune response by facilitating the processing of antigens; and limit the chance for an errant adaptive response by facilitating the PMN's clearance once it is apoptotic. The following objectives will provide information necessary for addressing the larger immunologic questions: 1) determine whether calreticulin uses its KDEL sequence for transport to the plasma membrane, and whether other factors such as stress and apoptosis affect transport and/or shedding; 2) define the reciprocal binding domains on calreticulin and CD59 using recombinant domains of calreticulin and sCD59 with selected mutations. Kinetic, real time binding will be monitored with surface plasmon resonance; 3) Define if ligating ecto-calreticulin induces unique intracellular signaling. The immune functions of PMN derived calreticulin will be largely determined by the biology of calreticulin-CD59 interaction. The results of the proposed calreticulin-CD59 studies will enable future studies on the potential dual roles of PMN ecto-calreticulin for priming adaptive immunity, a function that is relevant to vaccine design; and for augmenting the clearance of apoptotic PMN, a function that prevents autoimmunity.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Allergy and Immunology Study Section (ALY)
Program Officer
Winter, David B
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Beth Israel Deaconess Medical Center
United States
Zip Code
Karnchanaphanurach, Pallop; Mirchev, Rossen; Ghiran, Ionita et al. (2009) C3b deposition on human erythrocytes induces the formation of a membrane skeleton-linked protein complex. J Clin Invest 119:788-801
Ghiran, Ionita; Glodek, Aleksandra M; Weaver, Gregory et al. (2008) Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1. Blood 112:3465-73
Chen, C-H; Ghiran, I; Beurskens, F J M et al. (2007) Antibody CR1-2B11 recognizes a non-polymorphic epitope of human CR1 (CD35). Clin Exp Immunol 148:546-54
Pilsczek, Florian H; Nicholson-Weller, Anne; Ghiran, Ionita (2005) Phagocytosis of Salmonella montevideo by human neutrophils: immune adherence increases phagocytosis, whereas the bacterial surface determines the route of intracellular processing. J Infect Dis 192:200-9
Repik, A; Pincus, S E; Ghiran, I et al. (2005) A transgenic mouse model for studying the clearance of blood-borne pathogens via human complement receptor 1 (CR1). Clin Exp Immunol 140:230-40